| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |